VOR

Vor Biopharma Inc.

Price

$23.58

return (12m)

-42.49%

p/e

1.98

p/bv

-6.20

DIVIDEND YIELD

0.00%

VOR price

Vor Biopharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment VOR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

23.20%

3 months

56.78%

1 year

-42.49%

2 years

24.11%

5 years

-91.12%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals VOR

Valuation

P/E

1.98

Sector -4.38

Industry -4.38

P/BV

-6.20

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-16.20

Sector -263.09

Industry -263.09

EV/EBIT

-16.19

Sector -702.90

Industry -702.90

P/EBITDA

-8.44

Sector -4.39

Industry -4.39

P/EBIT

-8.44

Sector -4.73

Industry -4.73

P/Total Assets

2.58

Sector 1.49

Industry 1.49

P/Net Current Assets

-6.02

Sector -11.70

Industry -11.70

P/Working Capital

2.76

Sector -3.19

Industry -3.19

EPS

11.63

Sector -2.14

Industry -2.14

BVPS

-3.71

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-313.58%

Sector -65.14%

Industry -65.14%

ROA

130.50%

Sector -65.53%

Industry -65.53%

ROIC

-1,895.26%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

19.15

Sector 2.90

Industry 2.90

Net Debt / EBITDA

9.75

Sector -6.07

Industry -6.07

Net Debt / EBIT

9.74

Sector -8.26

Industry -8.26

Net Debt / Equity

2.33

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

-0.42

Sector 0.41

Industry 0.41

Liabilities/Assets

1.42

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals VOR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
VOR Vor Biopharma Inc.	$23.58	-42.21%	0.00%	1.98	-6.20	-313.58%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

VOR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Vor Biopharma

Vor Biopharma Inc.

Average Investor10 user rating

4.0 (1 people)

United States

11 years

Founded: 2015

2021

Time since IPO - 5 years

88

Employees

Vor Biopharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.24 billion, with shareholders equity totaling $-200.20 million.

The company employs approximately 88 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Vor Biopharma Inc. reported $- in revenue, generating net income of $627.78 million.

Key financial metrics include a P/E ratio of 1.98, a price-to-book (P/B) ratio of -6.20, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker VOR.

Market cap

$1.24 billion

Net worth

$-200.20 million

$-200,200,000.00

Assets

$481.05 million

$481,050,000.00

Total Shares Outstanding

54.00 million

54,000,000

Average Daily Trading Volume

$1.26 million

$1,262,508.00

Sector

Health Care

Industry

Biotechnology

VOR

VOR revenue and profits

Financial Results VOR

DRAG THE FRAME TO SEE MORE DATA

VOR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Vor Biopharma (VOR) today?

A cotação de Vor Biopharma (VOR) hoje está em US$ 23.58, com uma variação de -42.49% em relação ao último ano. A cotação de Vor Biopharma (VOR) iniciou o ano negociando na casa dos US$ 13.08 e hoje está em US$ 23.58. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Vor Biopharma (VOR) e dados de ações do Ibovespa e mercados internacionais.

Quando Vor Biopharma (VOR) paga dividendos?

Vor Biopharma (VOR) não distribuiu dividendos no último ano.

Is Vor Biopharma (VOR) a good investment?

Atualmente, Vor Biopharma (VOR) está cotada a US$ 23.58, com um P/L de 1.98, representando um desvio de -71% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -42.49 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -42.49%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Vor Biopharma (VOR) stock?

Investir em ações de Vor Biopharma (VOR) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Vor Biopharma (VOR) yield today?

A rentabilidade de Vor Biopharma (VOR) foi de 23.20% no último mês, -42.49% no último ano e -91.12% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Vor Biopharma (VOR) hoje, o investimento total seria de US$ 2,358.00, com base na cotação atual de US$ 23.58.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,356.09
Em 5 anos: US$ 209.39
Em 10 anos: US$ 2,358.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

VOR

Vor Biopharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment VOR

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING VOR WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Vor Biopharma

Vor Biopharma Inc.

United States

11 years

2021

88

PROFIT X PRICE VOR

Financial Results VOR

VOR cash flow

Asset, Revenue and Profit Growth - VOR

VOR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions